“

Working with G4A has shaved months off of our “go to market” timeline. It has been instrumental in providing valuable guidance and exposure to specialists, relevant information in all of the appropriate technical and business areas necessary for getting a medical products company started. - Joe Curcio, CEO, Kinaptic.

“

Working with G4A has shaved months off of our “go to market” timeline. It has been instrumental in providing valuable guidance and exposure to specialists, relevant information in all of the appropriate technical and business areas necessary for getting a medical products company started. - Joe Curcio, CEO, Kinaptic.

“

The program is tailor-made for digital health companies, taking you from validating your idea, connecting you to the right stakeholders within the organization, and providing you the essential tools to build your product all the way to commercialization and partnerships. - Michal Meiri, Co-Founder & CEO, Agamon.

“

Our algorithm detects micro-movements through the sensors built into smartphones and wearables and translates them into daily activities that have an impact on your condition. By taking into account these digital biomarkers, it is possible to put symptoms into context and predict their occurrence before it is too late. - Sebastian Sujka, CEO, xbird.

“

Our algorithm detects micro-movements through the sensors built into smartphones and wearables and translates them into daily activities that have an impact on your condition. By taking into account these digital biomarkers, it is possible to put symptoms into context and predict their occurrence before it is too late. - Sebastian Sujka, CEO, xbird.

“

Participating in Grants4Apps helped us to bring our home pharmacy app to the next level. The contacts we made were not only a huge value to our startup, but also of value for a lifetime. - Kerti Alev, CEO, MediKeep.